Monthly Archives: March 2016

Coalition Comments on PET GMP Recordkeeping Burden

Posted on March 1, 2016 by C. Kubler

On February 29, 2016, the Coalition submitted comments to the FDA on the burdens associated with the PET drug Good Manufacturing Practice (GMP) regulations at 21 CFR part 212. As previously reported, the FDA issued a Federal Notice on December … Continue reading →

Posted in PET Drugs | Leave a comment